Basel Medical Group Ltd Ordinary Shares (BMGL) — Capital Reinvestment Ratio
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($2.51 Million) in capital expenditures ($7.92K). See cash generation quality of Basel Medical Group Ltd Ordinary Shares to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Basel Medical Group Ltd Ordinary Shares Capital Reinvestment Ratio (2022–2024)
This chart tracks Basel Medical Group Ltd Ordinary Shares's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Basel Medical Group Ltd Ordinary Shares (2022–2024)
Year-by-year Capital Reinvestment Ratio for Basel Medical Group Ltd Ordinary Shares from 2022 to 2024. For live market cap and broader valuation context, see Basel Medical Group Ltd Ordinary Shares market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $2.51 Million | $7.92K | ▲ +33.2% |
| 2023 | 0.00x | $2.60 Million | $6.16K | ▼ -92.5% |
| 2022 | 0.03x | $2.79 Million | $88.50K | — |